| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 259.00M | 181.70M | 169.80M | 154.10M | 145.60M |
| Gross Profit | 232.00M | 155.70M | 151.00M | 141.50M | 135.60M |
| EBITDA | 207.00M | 94.70M | 0.00 | 163.20M | 132.30M |
| Net Income | 119.00M | 41.40M | 27.30M | 56.30M | 140.10M |
Balance Sheet | |||||
| Total Assets | 6.04B | 2.79B | 2.83B | 2.86B | 2.85B |
| Cash, Cash Equivalents and Short-Term Investments | 20.00M | 3.50M | 13.70M | 29.10M | 33.40M |
| Total Debt | 3.31B | 1.34B | 1.33B | 1.30B | 1.28B |
| Total Liabilities | 3.48B | 1.42B | 1.40B | 1.38B | 1.35B |
| Stockholders Equity | 2.55B | 1.38B | 1.42B | 1.48B | 1.50B |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 135.20M | 133.60M | 79.30M | 246.60M |
| Operating Cash Flow | 104.00M | 135.20M | 133.60M | 79.30M | 100.20M |
| Investing Cash Flow | -464.00M | -20.60M | -44.60M | -47.30M | -147.10M |
| Financing Cash Flow | 376.00M | -114.30M | -114.90M | -37.00M | -22.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £3.81B | 3.98 | 7.75% | 5.85% | -20.83% | ― | |
73 Outperform | £4.11B | 10.57 | 5.78% | 5.30% | 35.06% | 127.62% | |
73 Outperform | £4.36B | 11.16 | 3.85% | 6.34% | 10.69% | 135.58% | |
69 Neutral | £2.68B | 3.50 | 8.78% | 2.58% | -0.04% | 655.16% | |
68 Neutral | £1.49B | 12.28 | 4.88% | 4.25% | 1.66% | 11.42% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | £2.48B | 14.75 | 6.03% | 7.30% | 0.96% | ― |